{"altmetric_id":198228,"counts":{"readers":{"mendeley":2,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["antibody_news"],"posts_count":1}},"citation":{"abstract":"The consequences of current intensive chemotherapy for childhood acute lymphoblastic leukemia (ALL) for immune defense are a matter of concern. The purpose of this study was to examine the effect of reduced compared with intensive (conventional) ALL chemotherapy on serum immunoglobulin levels and specific antibody concentrations against vaccine-preventable diseases.","abstract_source":"pubmed","altmetric_jid":"4f6fa6313cf058f610008482","authors":["van Tilburg, Cornelis M.","Bierings, Marc B.","Berbers, Guy A.M.","Wolfs, Tom F.W.","Pieters, Rob","Bloem, Andries C.","Sanders, Elisabeth A.M."],"doi":"10.1002\/pbc.23258","endpage":"707","first_seen_on":"2011-07-26T23:40:01+00:00","issns":["1545-5017"],"issue":"5","journal":"Pediatric Blood and Cancer","last_mentioned_on":1311722401,"links":["http:\/\/onlinelibrary.wiley.com\/resolve\/doi?DOI=10.1002\/pbc.23258"],"pdf_url":"http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.23258\/pdf","pmid":"21793184","pubdate":"1970-01-01T01:00:00+00:00","publisher":"Wiley Subscription Services, Inc., A Wiley Company","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"},{"name":"Paediatrics And Reproductive Medicine","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"701","subjects":["neoplasms","hematology","pediatrics"],"title":"Impact of treatment reduction for childhood acute lymphoblastic leukemia on serum immunoglobulins and antibodies against vaccine\u00e2\u0080\u0090preventable diseases","type":"article","volume":"58","mendeley_url":"http:\/\/www.mendeley.com\/research\/impact-treatment-reduction-childhood-acute-lymphoblastic-leukemia-serum-immunoglobulins-antibodies-a"},"altmetric_score":{"score":0.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":3685758,"mean":4.9523304688866,"rank":2947597,"this_scored_higher_than_pct":1,"this_scored_higher_than":72310,"rank_type":"exact","sample_size":3685758,"percentile":1},"similar_age_3m":{"total_number_of_other_articles":54758,"mean":4.5749351863689,"rank":37759,"this_scored_higher_than_pct":1,"this_scored_higher_than":248,"rank_type":"exact","sample_size":54758,"percentile":1},"this_journal":{"total_number_of_other_articles":1082,"mean":1.9796484736355,"rank":935,"this_scored_higher_than_pct":1,"this_scored_higher_than":5,"rank_type":"exact","sample_size":1082,"percentile":1},"similar_age_this_journal_3m":{"total_number_of_other_articles":20,"mean":1.5237894736842,"rank":12,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":20,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":[],"by_discipline":[]}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/#!\/Antibody_News\/status\/95996824908865536","citation_ids":[198228],"posted_on":"2011-07-26T23:20:01+00:00","author":{"name":"Luke Scicluna","image":"http:\/\/a0.twimg.com\/sticky\/default_profile_images\/default_profile_0_normal.png","description":"","id_on_source":"antibody_news","tweeter_id":"124099395","followers":68},"tweet_id":"95996824908865536"}]}}